Navigation Links
Surveyed U.S. and European Neurologists Agree that a Therapy's Effect on Physical Disability is the Most Important Attribute Influencing Prescribing Decisions in Secondary-Progressive Multiple Sclerosis
Date:3/20/2013

BURLINGTON, Mass., March 20, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European neurologists agree that a therapy's effect on physical disability is the most influential attribute when making prescribing decisions for secondary-progressive multiple sclerosis (SP-MS)*. These same neurologists cite a therapy's effect on quality of life as the second-most important attribute, ahead of an effect on relapses, imaging metrics and other functional domains.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO)

Current management of SP-MS relies on the use of mainline disease-modifying therapies (which include interferon-betas and Teva's Copaxone), most of which are approved broadly for the treatment of relapsing forms of MS. This category encompasses relapsing-remitting MS (RR-MS) and SP-MS patients who continue to experience relapses. Interviewed thought leaders suggest that, based on data in RR-MS, Genzyme/Sanofi/Bayer HealthCare's Lemtrada may offer advantages over sales-leading Copaxone on measures of physical disability—potentially translating into clinical benefits for SP-MS patients. 

"The neurologists we surveyed indicate that an improved effect on physical disability is one of the greatest unmet needs in SP-MS," said Decision Resources Analyst Georgiana L. Kuhlmann , S.M. "Drawing on clinical data from RR-MS trials, interviewed thought leaders indicate that Lemtrada has demonstrated the potential to partially fulfill this unmet need."

According to the DecisionBase 2013 report entitled On What Attributes Will Neurologists and Payers Differentiate Novel Therapies for Secondary-Pro
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. According to Surveyed Oncologists in the EU5, Zytiga Has Heavily Penetrated Second-Line Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC) and is Displacing Jevtana to Later-Line mCRPC
2. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
3. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
4. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
5. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
6. Mylan Launches Generic Lipitor® in Five European Countries
7. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
8. Bristol-Myers Squibb to Present New Data on ORENCIA(R)? (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
9. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
10. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
11. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... OAK, Mich. , March 26, 2015 ... have performed the Midwest,s first commercial implant of ... Administration for patients with non-valvular atrial fibrillation. The Watchman ... long-term use of blood-thinning warfarin medication to reduce the ... most common heart rhythm disorder affecting more than 5 ...
(Date:3/26/2015)... , March 26, 2015 When ... by their existing PACS vendor their system would ... determined that they needed a better structured solution ... selected Avreo interWORKS due to its interface capabilities ... meaningful use standards through to the hospital,s radiology ...
(Date:3/26/2015)... DALLAS , March 26, 2015  CCS ... of home medical supplies for patients with chronic ... President and Chief Executive Officer, effective March 23.  ... second-largest telehealth company, where he was President of ... Carson was President and Executive Vice President of ...
Breaking Medicine Technology:Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2CCS Medical Team Hires Industry Operator Rodney Carson as CEO 2
... Calif., Aug. 31 Accuray Incorporated (Nasdaq: ARAY ... today financial results for the fourth quarter and fiscal year ... fourth quarter of fiscal 2010, Accuray reported total revenue of ... of fiscal 2009 total revenue of $58.8 million. For the ...
... 31 Reportlinker.com announces that a new market research report is ... the Coronary Stent Market http://www.reportlinker.com/p0203108/All-Change-in-the-Coronary-Stent-Market.html ... the prospects for key stent sectors Evaluate how ... and split in major regions and technology sectors ...
Cached Medicine Technology:Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 2Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 3Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 4Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 5Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 6Reportlinker Adds All Change in the Coronary Stent Market 2Reportlinker Adds All Change in the Coronary Stent Market 3Reportlinker Adds All Change in the Coronary Stent Market 4Reportlinker Adds All Change in the Coronary Stent Market 5Reportlinker Adds All Change in the Coronary Stent Market 6Reportlinker Adds All Change in the Coronary Stent Market 7Reportlinker Adds All Change in the Coronary Stent Market 8Reportlinker Adds All Change in the Coronary Stent Market 9
(Date:3/27/2015)... (PRWEB) March 27, 2015 Smile Brands ... providers of business support services to dental groups in ... an affiliated Castle Dental office in Hendersonville, ... Hendersonville, TN 37075, this new Castle Dental office provides ... receive the latest in comprehensive, quality dental care. Hendersonville ...
(Date:3/27/2015)... March 27, 2015 In light of ... number 1:15-cv-10429, U.S. District Court, District of Massachusetts; and ... Eastern District of Pennsylvania), the San Diego personal injury ... A.P.C. are announcing that they are available to investigate ... women who were prescribed Zofran while pregnant and who ...
(Date:3/26/2015)... Dr. Rod J. Rohrich, who served ... and has trained over 6500 surgeons through these ... based medicine (EBM), that is, the optimization of decision ... "We often hear from rhinoplasty surgeons who ... certainly not trying to stifle these discussions, we do ...
(Date:3/26/2015)... Florida Hospital teamed up with ABC Action ... campaign and live Dr. Oz event, which took place at ... than a thousand people came out to see Dr. Mehmet ... The world renowned cardiothoracic surgeon and Emmy award winning talk ... a panel of experts for the live health expo. Florida ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 Behavioral ... consulting firm, announced the release of BathroomMap® , ... to increase access to public restrooms for travelers, especially ... bathroom apps, BathroomMap does not facilitate a paid, social ... to identify and rate local establishments that have clean, ...
Breaking Medicine News(10 mins):Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 2Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 3Health News:The Law Office of Melinda J. Helbock, A.P.C. Announces That It Is Now Accepting Case Reviews for Potential Zofran Birth Defect Lawsuits 2Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 3Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3
... on genetic puzzle to try to save the mammals , ... better understanding of an outbreak of cancerous tumors that is ... report. , Devil facial tumor disease, a kind of cancer ... physical contact, is one of only two types of cancer ...
... unavoidable, expert says , THURSDAY, Dec. 31 (HealthDay News) -- ... among the elderly. , The notion is drawn from a ... the activities of over 1,000 physically active men and women ... , Those who spent time volunteering were less likely to ...
... ... Marketing. We,ve seen a restaurant chain launched promotion that sold out in 90 minutes using ... ... of 2009 and closed, there were a handful that took the path less beaten and ...
... , WARMINSTER, Pa., Dec. 31 ... company, reports brisk sales for its recently launched, New Year,s ... for home gardeners who want to make New Year,s resolutions and ... giant seedpack contains varieties of vegetables and flowers to help lose ...
... , , WASHINGTON, Dec. 31 ... Campaign for Tobacco-Free Kids: , (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ... historic step for health when it becomes the first major ... all restaurants and bars. This new law will protect ...
... with not just more but sicker residents, , THURSDAY, Dec. ... say the nation,s health-care system is not prepared to deal ... the 78-million-strong baby-boom generation are about to turn 65. And ... older than 65 will double, according to a report on ...
Cached Medicine News:Health News:Clues to Cancer That Could Wipe Out Tasmanian Devils 2Health News:Volunteering May Keep Elderly Stronger 2Health News:Volunteering May Keep Elderly Stronger 3Health News:Small Businesses In Singapore Outmarkets & Outperforms Bigger Players in Tough Economy With Online Marketing 2Health News:New Year's Resolution Garden Growing Sales for Burpee 2Health News:North Carolina Goes Smoke-Free on Jan. 2 in Historic Step for Health 2Health News:North Carolina Goes Smoke-Free on Jan. 2 in Historic Step for Health 3Health News:As U.S. Ages, Health Care May Need to Change 2Health News:As U.S. Ages, Health Care May Need to Change 3
... FLUOstar is a flexible multifunction plate reader ... one instrument: fluorescence intensity, time-resolved fluorescence, high-perfomance ... be equipped with injectors that deliver reagent ... fast kinetic cell assays can be performed ...
The basic modular Wallac 1420 VICTOR2 is a manually operated platereader which enables luminometry, fluorometry and photometry measurements to be made....
VICTOR2 V measures prompt fluorescence, fluorescence polarization, luminescence, time-resolved fluorescence and absorbance. This model includes high density TRF (for 1536-well plates), temperature ...
This is the modular VICTOR2 multilabel counter with the TR-fluorometry, stacker and robot loading options.The addition of a xenon flash lamp brings the time-resolved fluorescence counting mode to th...
Medicine Products: